Display options
Share it on

Exp Ther Med. 2017 Oct;14(4):3314-3318. doi: 10.3892/etm.2017.4856. Epub 2017 Jul 31.

Tirofiban facilitates the reperfusion process during endovascular thrombectomy in ICAS.

Experimental and therapeutic medicine

Hongchen Zhao, Jinhua Zhang, Danyan Gu, Zongjie Shi, Jie Pan, Yu Geng, Tianming Shi

Affiliations

  1. Department of Neurology, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014, P.R. China.
  2. Department of Intensive Care Medicine, Xiasha Hospital, Hangzhou, Zhejiang 310018, P.R. China.

PMID: 28912883 PMCID: PMC5585762 DOI: 10.3892/etm.2017.4856

Abstract

The aim of the present study was to assess the use of tirofiban injections for rescue therapy following artery reocclusion due to intra-luminal thrombosis during endovascular thrombectomy in patients with acute ischemic stroke (AIS). A total of seven cases of patients treated with adjunctive tirofiban injections following failed endovascular thrombectomy due to instant intra-luminal thrombosis were retrospectively assessed. A Solitaire stent was used as the primary thrombectomy device in all patients. Tirofiban was injected intra-arterially via a temporarily deployed Solitaire stent with continuous intravenous infusion for the subsequent 24 h; half of the conventionally recommended dose was employed. Outcome measures included angiographic reperfusion (mTICI), symptomatic intracranial hemorrhage, mortality and functional independence at 90 days (modified Rankin Scale, 0-2). Six patients had occlusions in the middle cerebral artery and one patient had occlusions in the basilar artery. Of the seven patients, five exhibited successful reperfusion (mTICI 2b-3) and achieved functional independence following 90 days. Reperfusion failed in the remaining two patients, who succumbed within 90 days of therapy. No intracranial or extracranial hemorrhage cases were identified. The results of the present study suggest that tirofiban facilitates reperfusion and ameliorates long-term prognosis in patients with AIS undergoing endovascular thrombectomy, and may be safe for those receiving intravenous tissue plasminogen activator therapy.

Keywords: acute ischemic stroke; endovascular thrombectomy; intra-luminal thrombosis; tirofiban

References

  1. AJNR Am J Neuroradiol. 2016 Jun 16;:null - PubMed
  2. Stroke. 2016 Oct;47(10 ):2649-51 - PubMed
  3. Cerebrovasc Dis. 2014;37(5):350-5 - PubMed
  4. Stroke. 2015 Oct;46(10):3020-35 - PubMed
  5. N Engl J Med. 2015 Jun 11;372(24):2285-95 - PubMed
  6. N Engl J Med. 2015 Mar 12;372(11):1009-18 - PubMed
  7. Arch Neurol. 2003 Nov;60(11):1561-4 - PubMed
  8. Lancet. 2007 Jan 27;369(9558):275-82 - PubMed
  9. J Stroke. 2016 Jan;18(1):96-101 - PubMed
  10. Neurosurgery. 2015 Jun;76(6):680-6; discussion 686 - PubMed
  11. Stroke. 2007 Sep;38(9):2592-4 - PubMed
  12. AJNR Am J Neuroradiol. 2015 Mar;36(3):552-6 - PubMed
  13. Neuroepidemiology. 2003 Jan-Feb;22(1):37-40 - PubMed
  14. Clin Neurol Neurosurg. 2012 Dec;114(10):1316-9 - PubMed
  15. N Engl J Med. 2011 Sep 15;365(11):993-1003 - PubMed
  16. Neurointervention. 2015 Feb;10(1):22-7 - PubMed
  17. N Engl J Med. 2015 Jan 1;372(1):11-20 - PubMed
  18. N Engl J Med. 2015 Mar 12;372(11):1019-30 - PubMed
  19. JAMA. 2015 Mar 24-31;313(12):1240-8 - PubMed
  20. N Engl J Med. 2015 Jun 11;372(24):2296-306 - PubMed
  21. Stroke. 1988 Jun;19(6):681-7 - PubMed
  22. Stroke. 2014 Mar;45(3):663-9 - PubMed
  23. Neuroradiology. 2011 Oct;53(10):779-85 - PubMed
  24. Stroke. 2012 Oct;43(10):2682-8 - PubMed
  25. Neuroradiology. 2014 May;56(5):397-403 - PubMed
  26. Stroke. 2013 May;44(5):1453-5 - PubMed
  27. AJNR Am J Neuroradiol. 2008 Feb;29(2):253-8 - PubMed

Publication Types